ERBB2 and breast carcinoma: According to immunohistochemical and transcriptomic criteria [1], breast cancer can be divided into three subtypes: (1) tumors that express hormonal receptors, so-called luminal; (2) cancers that overexpress the transmembrane tyrosine kinase HER2; and (3) tumors that do not overexpress any of the above-mentioned proteins, the so called triple negative breast cancers (TNBC).